Page 2 - Nrols News Today : Breaking News, Live Updates & Top Stories | Vimarsana

STOCKHOLM, Nov. 24, 2021 /PRNewswire/ InDex Pharmaceuticals Holding AB (publ) today announced that the first patient has been enrolled in the pivotal phase III study CONCLUDE. The study will

William sandbornWalter reinischRaja atreyaPeter zerhouniUniversity of california san diegoPrnewswire index pharmaceuticals holdingKindex pharmaceuticalsIndex pharmaceuticals holdingUniversity of erlangenUniversity of viennaProfessor raja atreyaCalifornia san diegoProfessor walter reinischMedical universityMedical advisorsAbuse regulation